@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns2: <http://purl.org/vocab/frbr/core#> .
@prefix ns3: <http://purl.org/spar/pro/> .
@prefix ns4: <http://purl.org/spar/datacite/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/061303519334> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 061303519334" ;
    ns1:publicationDate "2022-11-23"^^xsd:date ;
    dcterms:title "N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides As Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights Into The Mechanism Of Receptor Activation/Deactivation" ;
    ns4:hasIdentifier <https://w3id.org/oc/meta/id/061303262198>,
        <https://w3id.org/oc/meta/id/063201218144> ;
    ns3:isDocumentContextFor <https://w3id.org/oc/meta/ar/0613014184342>,
        <https://w3id.org/oc/meta/ar/0613014184343>,
        <https://w3id.org/oc/meta/ar/0613014184344>,
        <https://w3id.org/oc/meta/ar/0613014184345>,
        <https://w3id.org/oc/meta/ar/0613014184346>,
        <https://w3id.org/oc/meta/ar/0613014184347>,
        <https://w3id.org/oc/meta/ar/0613014184348>,
        <https://w3id.org/oc/meta/ar/0613014184349>,
        <https://w3id.org/oc/meta/ar/0613014184350>,
        <https://w3id.org/oc/meta/ar/0613014184351>,
        <https://w3id.org/oc/meta/ar/0613014184352> ;
    ns2:embodiment <https://w3id.org/oc/meta/re/061302535625> ;
    ns2:partOf <https://w3id.org/oc/meta/br/061303520089> .